Vyepti

Chemical Nameeptinezumab-jjmr
Dosage FormInjectable (intravenous; 100 mg/mL)
Drug ClassReceptor antagonists
SystemNervous
CompanyLundbeck
Approval Year2020

Indication

  • Vyepti is indicated for the preventive treatment of migraine in adults.
Last updated on 10/23/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Vyepti (eptinezumab-jjmr) Prescribing Information2020Lundbeck
Document TitleYearSource
VA/DoD clinical practice guidelines: the primary care management of headache.2020U.S Department of Veteran Affairs